Search Login Register

VLDL Lipoproteins Summary

Description: A class of lipoproteins of very light (0.93-1.006 g/ml) large size (30-80 nm) particles with a core composed mainly of TRIGLYCERIDES and a surface monolayer of PHOSPHOLIPIDS and CHOLESTEROL into which are imbedded the apolipoproteins B, E, and C. VLDL facilitates the transport of endogenously made triglycerides to extrahepatic tissues. As triglycerides and Apo C are removed, VLDL is converted to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LOW-DENSITY LIPOPROTEINS from which cholesterol is delivered to the extrahepatic tissues.

Also Known As: Lipoproteins, VLDL; Lipoprotein VLDL II; Lipoproteins, VLDL I; Lipoproteins, VLDL III; Lipoproteins, VLDL1 Show All >>

Networked: 408 relevant articles (6 outcomes, 32 trials/studies) for this Bio-Agent

Key Diseases for which VLDL Lipoproteins is Relevant

  1. Atherosclerosis : 1 outcome 4 studies in 36 results
  2. Hypertriglyceridemia : 1 outcome 2 studies in 46 results
  3. Coronary Disease (Coronary Heart Disease) : 1 outcome 2 studies in 13 results
  4. Coronary Artery Disease (Coronary Atherosclerosis) : 1 outcome 1 study in 10 results
  5. Stroke (Strokes) : 1 outcome 1 study in 4 results
Show All >>

Drugs Related to VLDL Lipoproteins

  1. Lipoproteins (Lipoprotein)
  2. Cholesterol
  3. Triglycerides (Triacylglycerol)
  4. Apolipoproteins B (ApoB)
  5. Chylomicrons
  6. Insulin (Novolin)
  7. Bile Acids and Salts (Bile Acids)
  8. HDL Lipoproteins
  9. LDL Lipoproteins (beta Lipoproteins)
  10. Apolipoproteins
Show All >>

Therapies Related to VLDL Lipoproteins

  1. Catheters
  2. Intravenous Injections
  3. Injections
  4. Renal Dialysis (Hemodialysis)
  5. Drug Therapy (Chemotherapy)

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.